Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elnaz Agi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Immunology Letters|June 13, 2017
Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse modelSomayeh Kadkhodayan, Behnaz Sadat Jafarzade, Seyed Mehdi Sadat, et al.
International Journal of Pharmaceutics|November 2, 2025
From simulation to immunization: efficient non-viral delivery of HIV-1 Nef<sup>mut</sup>-Tat DNA construct using CM18-TAT11 cell penetrating peptideMostafa Gheydi, Azam Bolhassani, Babak Negahdari, et al.
International Immunopharmacology|December 3, 2022
Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytesAlireza Milani, Elnaz Agi, Mohammad Hassan Pouriayevali, et al.
Microbial Pathogenesis|June 15, 2024
Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidateLeila Sadeghi, Azam Bolhassani, Elham Mohit, et al.
Archives of Virology|November 15, 2014
Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirusAfshin Khavari, Azam Bolhassani, Fatemeh Alizadeh, et al.
Immunology Letters|November 1, 2015
Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responsesAzam Bolhassani, Kimia Kardani, Rouhollah Vahabpour, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 10, 2022
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487PheAysan Fallah, Mahmood Shams, Elnaz Agi, et al.
Pathogens and Disease|June 15, 2022
Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytesElahe Akbari, Soheila Ajdary, Esmat Mirabzadeh Ardakani, et al.
Human Vaccines & Immunotherapeutics|February 11, 2015
Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic LeishmaniaAzam Bolhassani, Martin Muller, Farzin Roohvand, et al.
Pediatric Hematology and Oncology|March 20, 2019
Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patientsNiloofar Naderi, Hossein Yousefi, Sahar Mollazadeh, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Immunology Letters|June 13, 2017
Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse modelSomayeh Kadkhodayan, Behnaz Sadat Jafarzade, Seyed Mehdi Sadat, et al.
International Journal of Pharmaceutics|November 2, 2025
From simulation to immunization: efficient non-viral delivery of HIV-1 Nef<sup>mut</sup>-Tat DNA construct using CM18-TAT11 cell penetrating peptideMostafa Gheydi, Azam Bolhassani, Babak Negahdari, et al.
International Immunopharmacology|December 3, 2022
Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytesAlireza Milani, Elnaz Agi, Mohammad Hassan Pouriayevali, et al.
Microbial Pathogenesis|June 15, 2024
Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidateLeila Sadeghi, Azam Bolhassani, Elham Mohit, et al.
Archives of Virology|November 15, 2014
Chemo-immunotherapy using saffron and its ingredients followed by E7-NT (gp96) DNA vaccine generates different anti-tumor effects against tumors expressing the E7 protein of human papillomavirusAfshin Khavari, Azam Bolhassani, Fatemeh Alizadeh, et al.
Immunology Letters|November 1, 2015
Prime/boost immunization with HIV-1 MPER-V3 fusion construct enhances humoral and cellular immune responsesAzam Bolhassani, Kimia Kardani, Rouhollah Vahabpour, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 10, 2022
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487PheAysan Fallah, Mahmood Shams, Elnaz Agi, et al.
Pathogens and Disease|June 15, 2022
Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytesElahe Akbari, Soheila Ajdary, Esmat Mirabzadeh Ardakani, et al.
Human Vaccines & Immunotherapeutics|February 11, 2015
Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic LeishmaniaAzam Bolhassani, Martin Muller, Farzin Roohvand, et al.
Pediatric Hematology and Oncology|March 20, 2019
Inflammatory and immune response genes: A genetic analysis of inhibitor development in Iranian hemophilia A patientsNiloofar Naderi, Hossein Yousefi, Sahar Mollazadeh, et al.
Pageof 3